The analysis of clinic-pathological parameters in the much larger TARGET cohort, consisting of 264 patients with a precursor T-cell neoplasm, revealed additional correlations between FADD expression and poor outcome factors. Here, FADD is linked to T-cell and NK-cell neoplasm.